By Femtech Insider Breast Health, Cancer, News, Pharma, Regulatory October 16, 2024 ShareTwitterFacebookPinterest-circled FDA Approves Genentech’s Itovebi for Advanced Breast Cancer with PIK3CA Mutation
By Femtech Insider Breast Health, Cancer, News, Pharma October 1, 2024 ShareTwitterFacebookPinterest-circled FDA Approves Novartis’ Kisqali for Early Breast Cancer
By Femtech Insider Acquisition, News, Pharma September 19, 2024 ShareTwitterFacebookPinterest-circled Organon to Acquire Roivant’s Dermatology Subsidiary for Up to $1.2B
By Femtech Insider Fertility, News, Pharma, Reproductive Health September 16, 2024 ShareTwitterFacebookPinterest-circled Organon Partners with BaoPharma to Bring Innovative Long-Acting FSH Treatment to China
By Femtech Insider Digital Health, Menopause, News, Pharma September 13, 2024 ShareTwitterFacebookPinterest-circled Bayer Launches New Healthy-Aging Ecosystem
By Femtech Insider Fertility, News, Pharma August 28, 2024 ShareTwitterFacebookPinterest-circled Fresenius Kabi Launches New Generic Version of Cetrorelix Acetate for Injection, a Medication Used in Fertility Care
By Femtech Insider Menopause, News, Pharma August 23, 2024 ShareTwitterFacebookPinterest-circled JAMA Publishes Positive Phase III Results for Bayer’s Elinzanetant in Treating Menopausal Hot Flashes
By Femtech Insider News, Pharma July 17, 2024 ShareTwitterFacebookPinterest-circled Lupin Divests U.S. Women’s Health Specialty Business to Evofem, Including BV Drug SOLOSEC
